535 related articles for article (PubMed ID: 24894658)
1. Swallowed topical corticosteroids reduce the risk for long-lasting bolus impactions in eosinophilic esophagitis.
Kuchen T; Straumann A; Safroneeva E; Romero Y; Bussmann C; Vavricka S; Netzer P; Reinhard A; Portmann S; Schoepfer AM
Allergy; 2014 Sep; 69(9):1248-54. PubMed ID: 24894658
[TBL] [Abstract][Full Text] [Related]
2. Swallowed Fluticasone Propionate Is an Effective Long-Term Maintenance Therapy for Children With Eosinophilic Esophagitis.
Andreae DA; Hanna MG; Magid MS; Malerba S; Andreae MH; Bagiella E; Chehade M
Am J Gastroenterol; 2016 Aug; 111(8):1187-97. PubMed ID: 27325220
[TBL] [Abstract][Full Text] [Related]
3. Comparisons of Fluticasone to Budesonide in the Treatment of Eosinophilic Esophagitis.
Albert D; Heifert TA; Min SB; Maydonovitch CL; Baker TP; Chen YJ; Moawad FJ
Dig Dis Sci; 2016 Jul; 61(7):1996-2001. PubMed ID: 27093866
[TBL] [Abstract][Full Text] [Related]
4. Eosinophilic esophagitis--treatment of eosinophilic esophagitis with drugs: corticosteroids.
von Arnim U; Malfertheiner P
Dig Dis; 2014; 32(1-2):126-9. PubMed ID: 24603395
[TBL] [Abstract][Full Text] [Related]
5. Randomized controlled trial comparing aerosolized swallowed fluticasone to esomeprazole for esophageal eosinophilia.
Moawad FJ; Veerappan GR; Dias JA; Baker TP; Maydonovitch CL; Wong RK
Am J Gastroenterol; 2013 Mar; 108(3):366-72. PubMed ID: 23399553
[TBL] [Abstract][Full Text] [Related]
6. Serum eosinophil cationic protein is superior to mast cell tryptase as marker for response to topical corticosteroid therapy in eosinophilic esophagitis.
Schlag C; Pfefferkorn S; Brockow K; Haller B; Slotta-Huspenia J; Schulz S; von Werder A; Ring J; Schmid RM; Bajbouj M
J Clin Gastroenterol; 2014 Aug; 48(7):600-6. PubMed ID: 24177377
[TBL] [Abstract][Full Text] [Related]
7. Combined and Alternating Topical Steroids and Food Elimination Diet for the Treatment of Eosinophilic Esophagitis.
Reed CC; Safta AM; Qasem S; Angie Almond M; Dellon ES; Jensen ET
Dig Dis Sci; 2018 Sep; 63(9):2381-2388. PubMed ID: 29380175
[TBL] [Abstract][Full Text] [Related]
8. Retrospective Comparison of Fluticasone Propionate and Oral Viscous Budesonide in Children With Eosinophilic Esophagitis.
Fable JM; Fernandez M; Goodine S; Lerer T; Sayej WN
J Pediatr Gastroenterol Nutr; 2018 Jan; 66(1):26-32. PubMed ID: 28489670
[TBL] [Abstract][Full Text] [Related]
9. Budesonide Oral Suspension Improves Symptomatic, Endoscopic, and Histologic Parameters Compared With Placebo in Patients With Eosinophilic Esophagitis.
Dellon ES; Katzka DA; Collins MH; Hamdani M; Gupta SK; Hirano I;
Gastroenterology; 2017 Mar; 152(4):776-786.e5. PubMed ID: 27889574
[TBL] [Abstract][Full Text] [Related]
10. Eosinophilic Esophagitis: Impact of Latest Insights Into Pathophysiology on Therapeutic Strategies.
Schoepfer A; Safroneeva E; Straumann A
Dig Dis; 2016; 34(5):462-8. PubMed ID: 27333298
[TBL] [Abstract][Full Text] [Related]
11. Effects of topical steroids on tight junction proteins and spongiosis in esophageal epithelia of patients with eosinophilic esophagitis.
Katzka DA; Tadi R; Smyrk TC; Katarya E; Sharma A; Geno DM; Camilleri M; Iyer PG; Alexander JA; Buttar NS
Clin Gastroenterol Hepatol; 2014 Nov; 12(11):1824-9.e1. PubMed ID: 24681080
[TBL] [Abstract][Full Text] [Related]
12. Treatment outcomes for eosinophilic esophagitis in children with esophageal atresia.
Chan LJ; Tan L; Dhaliwal J; Briglia F; Clarkson C; Krishnan U
Dis Esophagus; 2016 Aug; 29(6):563-71. PubMed ID: 25872589
[TBL] [Abstract][Full Text] [Related]
13. Control of inflammation decreases the need for subsequent esophageal dilation in patients with eosinophilic esophagitis.
Runge TM; Eluri S; Woosley JT; Shaheen NJ; Dellon ES
Dis Esophagus; 2017 Jul; 30(7):1-7. PubMed ID: 29206905
[TBL] [Abstract][Full Text] [Related]
14. [Predictive factors of eosinophilic esophagitis in esophageal food bolus impaction].
Rodríguez-Sánchez J; López Viedma B; Verdejo Gil C; Martín Dávila F; Hernández Albujar A; Lorente Poyatos R; de La Santa Belda E; Martín Escobedo LR; Olmedo Camacho J
Rev Gastroenterol Mex; 2013; 78(1):5-11. PubMed ID: 23374542
[TBL] [Abstract][Full Text] [Related]
15. Eosinophilic esophagitis: analysis of food impaction and perforation in 251 adolescent and adult patients.
Straumann A; Bussmann C; Zuber M; Vannini S; Simon HU; Schoepfer A
Clin Gastroenterol Hepatol; 2008 May; 6(5):598-600. PubMed ID: 18407800
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of Budesonide vs Fluticasone for Initial Treatment of Eosinophilic Esophagitis in a Randomized Controlled Trial.
Dellon ES; Woosley JT; Arrington A; McGee SJ; Covington J; Moist SE; Gebhart JH; Tylicki AE; Shoyoye SO; Martin CF; Galanko JA; Baron JA; Shaheen NJ
Gastroenterology; 2019 Jul; 157(1):65-73.e5. PubMed ID: 30872104
[TBL] [Abstract][Full Text] [Related]
17. Dietary therapy can reverse esophageal subepithelial fibrosis in patients with eosinophilic esophagitis: a historical cohort.
Lieberman JA; Morotti RA; Konstantinou GN; Yershov O; Chehade M
Allergy; 2012 Oct; 67(10):1299-307. PubMed ID: 22913672
[TBL] [Abstract][Full Text] [Related]
18. Management guidelines of eosinophilic esophagitis in childhood.
Papadopoulou A; Koletzko S; Heuschkel R; Dias JA; Allen KJ; Murch SH; Chong S; Gottrand F; Husby S; Lionetti P; Mearin ML; Ruemmele FM; Schäppi MG; Staiano A; Wilschanski M; Vandenplas Y;
J Pediatr Gastroenterol Nutr; 2014 Jan; 58(1):107-18. PubMed ID: 24378521
[TBL] [Abstract][Full Text] [Related]
19. Long-term budesonide maintenance treatment is partially effective for patients with eosinophilic esophagitis.
Straumann A; Conus S; Degen L; Frei C; Bussmann C; Beglinger C; Schoepfer A; Simon HU
Clin Gastroenterol Hepatol; 2011 May; 9(5):400-9.e1. PubMed ID: 21277394
[TBL] [Abstract][Full Text] [Related]
20. Every-other-day Dosing of Oral Viscous Budesonide Is not Effective in the Management of Eosinophlic Esophagitis.
Rubinstein E; Hait EE; Mitchell PD; Lee JJ
J Pediatr Gastroenterol Nutr; 2018 Mar; 66(3):395-397. PubMed ID: 28837508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
